Skip to content

Clinical trials

Phase 3 Kidney Diseases trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Kidney Diseases Phase: Phase 3 Country / region: Taiwan Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20101
20121
20152
20201
20221
20232
20253
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting5
Completed4
Active, not recruiting3
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals4
Bayer2
AstraZeneca1
Dimerix Bioscience Pty Ltd1
Eli Lilly and Company1
Human Genome Sciences Inc., a GSK Company1
National Taiwan University Hospital1
Panion & BF Biotech Inc.1
Takeda1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Kidney Diseases13
Renal Insufficiency, Chronic7
Glomerulonephritis5
Urologic Diseases5
Glomerulonephritis, IGA4
Autoimmune Diseases2
Diabetes Mellitus, Type 22
Diabetic Nephropathies2
Nephritis2
Female Urogenital Diseases1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.